دورية أكاديمية
Development and professional validation of an App to support Oral Cancer Screening.
العنوان: | Development and professional validation of an App to support Oral Cancer Screening. |
---|---|
المؤلفون: | Rêgo TJRD; Centro Universitário Christus, Departamento de Odontologia, Fortaleza, Ceará, Brazil.; Universidade Federal do Ceará. Fortaleza, Ceará, Brazil., Lemos JVM; Centro Universitário Christus, Departamento de Odontologia, Fortaleza, Ceará, Brazil.; Universidade Federal do Ceará. Fortaleza, Ceará, Brazil., Matos APL; Centro Universitário Christus, Departamento de Odontologia, Fortaleza, Ceará, Brazil.; Universidade Federal do Ceará. Fortaleza, Ceará, Brazil., Caetano CFF; Centro Universitário Christus, Departamento de Odontologia, Fortaleza, Ceará, Brazil., Dantas TS; Centro Universitário Christus, Departamento de Odontologia, Fortaleza, Ceará, Brazil., Sousa FB; Centro Universitário Christus, Departamento de Odontologia, Fortaleza, Ceará, Brazil., Barros Filho EM; Centro Universitário Christus, Departamento de Odontologia, Fortaleza, Ceará, Brazil., Silva PGB; Centro Universitário Christus, Departamento de Odontologia, Fortaleza, Ceará, Brazil. |
المصدر: | Brazilian dental journal [Braz Dent J] 2022 Nov-Dec; Vol. 33 (6), pp. 44-55. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Dental Foundation of Ribeirão Preto Country of Publication: Brazil NLM ID: 9214652 Publication Model: Print Cited Medium: Internet ISSN: 1806-4760 (Electronic) Linking ISSN: 01036440 NLM ISO Abbreviation: Braz Dent J |
أسماء مطبوعة: | Original Publication: Ribeirão Preto : Dental Foundation of Ribeirão Preto, [1990- |
مواضيع طبية MeSH: | Early Detection of Cancer* , Mouth Neoplasms*/diagnosis, Humans |
مستخلص: | The objective of this study was to develop and validate an App for identifying risk factors for oral cancer. To this end, we developed an App (OCS: Oral Cancer Screening) with predictors of Oral Cancer (OC) and algorithm assembly to estimate the risk of its development. Methodology: Simulated clinical cases were designed so that 40 professionals with expertise in oral diagnostics could validate the algorithm and test its usability (SUS: System Usability Score) and acceptability (TAM: Technology Acceptance Model). Cronbach's alpha coefficient, Friedman/Dunn tests, and Spearman correlation evaluated the SUS and TAM scales. ROC curve was plotted to estimate the cutoff point of the algorithm in suggesting a high risk for OCS of the simulated cases. Chi-square and Fisher's exact tests were additionally used (p<0.05, SPSS v20.0). Results: Professionals with expertise in oral diagnosis had usability of 84.63±10.66 and acceptability of 84.75±10.62, which correlated positively (p<0.001, r=0.647). Acting in clinical areas of dentistry (p=0.034) and history of performing OC risk factor orientation (p=0.048) increased acceptability while acting in higher education increased usability (p=0.011). The cutoff point suggested by the App after validation of the simulated clinical cases showed high sensitivity of 84.8% and lower specificity of 58.4%. Conclusion: The OCS was effective and with adequate sensitivity, usability, and acceptability and may contribute to the detection of early oral lesions. |
References: | Oncol Nurs Forum. 2018 Jan 1;45(1):69-76. (PMID: 29251285) Telemed J E Health. 2019 Jun;25(6):492-498. (PMID: 30036174) Int J Cancer. 1984 Sep 15;34(3):335-7. (PMID: 6480154) Oral Oncol. 2019 Feb;89:59-65. (PMID: 30732960) JMIR Res Protoc. 2018 Dec 04;7(12):e11072. (PMID: 30514693) Dentomaxillofac Radiol. 2021 Sep 01;50(6):20200490. (PMID: 33705208) Telemed J E Health. 2019 Jun;25(6):462-470. (PMID: 30048216) Technol Health Care. 2017;25(2):187-195. (PMID: 27689559) Clin Oral Investig. 2020 Sep;24(9):3147-3155. (PMID: 31903501) JAMA Intern Med. 2014 Feb 1;174(2):269-74. (PMID: 24322569) Int J Palliat Nurs. 2017 Aug 2;23(8):394-401. (PMID: 28854054) CA Cancer J Clin. 2015 Sep-Oct;65(5):401-21. (PMID: 26215712) Methods Mol Biol. 2017;1571:343-356. (PMID: 28281266) Cien Saude Colet. 2014 Apr;19(4):1223-32. (PMID: 24820605) Contemp Clin Trials Commun. 2022 Feb 02;26:100898. (PMID: 35252622) Med Oral Patol Oral Cir Bucal. 2013 Jan 01;18(1):e33-7. (PMID: 23229266) J Nurs Res. 2020 Oct;28(5):e117. (PMID: 32501962) Telemed J E Health. 2017 Mar;23(3):192-199. (PMID: 27541205) World J Urol. 2008 Oct;26(5):423-9. (PMID: 18536878) Rev Bras Epidemiol. 2015 Oct-Dec;18(4):894-905. (PMID: 26982303) J Oral Pathol Med. 2019 Aug;48(7):595-603. (PMID: 31188491) Braz Oral Res. 2022 Jan 14;36:e008. (PMID: 35081226) Sultan Qaboos Univ Med J. 2020 May;20(2):e173-e178. (PMID: 32655909) Cad Saude Publica. 2013 Aug;29(8):1533-43. (PMID: 24005919) Bone Marrow Transplant. 2018 Apr;53(4):490-494. (PMID: 29330389) Braz Oral Res. 2014;28 Spec No:. (PMID: 24964281) Community Dent Oral Epidemiol. 2017 Feb;45(1):20-34. (PMID: 27642003) JMIR Cancer. 2017 Jan 06;3(1):e1. (PMID: 28410180) Br Dent J. 2018 Nov 9;225(9):815-819. (PMID: 30412550) CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593) Medicine (Baltimore). 2016 Jan;95(3):e2314. (PMID: 26817864) |
تواريخ الأحداث: | Date Created: 20221208 Date Completed: 20221215 Latest Revision: 20221215 |
رمز التحديث: | 20221215 |
مُعرف محوري في PubMed: | PMC9733366 |
DOI: | 10.1590/0103-6440202204895 |
PMID: | 36477964 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1806-4760 |
---|---|
DOI: | 10.1590/0103-6440202204895 |